BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 18374503)

  • 1. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M; Reis IM; Hamilton K
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.
    Abdel-Wahab M; Reis IM; Wu J; Duncan R
    Urology; 2009 Oct; 74(4):866-71. PubMed ID: 19628258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate brachytherapy and second primary cancer risk: a competitive risk analysis.
    Hinnen KA; Schaapveld M; van Vulpen M; Battermann JJ; van der Poel H; van Oort IM; van Roermund JG; Monninkhof EM
    J Clin Oncol; 2011 Dec; 29(34):4510-5. PubMed ID: 22025166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.
    Zelefsky MJ; Moughan J; Owen J; Zietman AL; Roach M; Hanks GE
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1053-61. PubMed ID: 15234039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
    Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
    Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
    Rusthoven K; Chen C; Raben D; Kavanagh B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.
    Takam R; Bezak E; Yeoh EE
    Phys Med Biol; 2009 Feb; 54(3):611-25. PubMed ID: 19124952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.
    Jani AB; Johnstone PA; Liauw SL; Master VA; Rossi PJ
    Am J Clin Oncol; 2010 Apr; 33(2):168-72. PubMed ID: 19745696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis.
    Singh AK; Mashtare TL; McCloskey SA; Seixas-Mikelus SA; Kim HL; May KS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1086-94. PubMed ID: 20350797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study.
    Lee CM; Szabo A; Shrieve DC; Macdonald OK; Tward JD; Skidmore TB; Gaffney DK
    Cancer; 2007 Nov; 110(9):2092-100. PubMed ID: 17849468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
    Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
    Bhojani N; Capitanio U; Suardi N; Jeldres C; Isbarn H; Shariat SF; Graefen M; Arjane P; Duclos A; Lattouf JB; Saad F; Valiquette L; Montorsi F; Perrotte P; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):342-8. PubMed ID: 20117287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
    Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
    BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate.
    Nijdam W; Levendag P; Noever I; Uyl-de Groot C; van Agthoven M
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):488-94. PubMed ID: 15145167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.